The Chinese retail drug market overly kept growing in 2014, however, with its decelerated growth of national macro-economy, the retailers would bear a burden of rising running cost, in addition, strictly on national medicare fees also led to a narrow growth capacity of drug retail business, that growth rate would fall back to 10% level or less.
Base on sale data from Ministry of Commerce of China in 2014, the market value of retail dug is estimated to $53 billion in 2015 at 9% growth rate, and CAGR 6.4% during 2015 to 2020 in China.
Total top 100 retailers accounted to 28.1% of market sales revenue, dropped 0.2% compared to 2013; top 10 also reached 15.2%, a little bit growth compared to 2013.
List of top 10 retailers:
|
|
Retailers |
Sales |
|
1 |
Guoda Drug Store |
1.20 |
|
2 |
Tongrentang |
0.99 |
|
3 |
Tongjunge |
0.91 |
|
4 |
Dashenlin |
0.84 |
|
5 |
Hongxiang |
0.80 |
|
6 |
LBX Pharmacy |
0.72 |
|
7 |
Nepsta Pharmacy |
0.55 |
|
8 |
Chendafangyuan |
0.52 |
|
9 |
Shanghai Huashipharmacy |
0.47 |
|
10 |
Yifeng Pharmacy |
0.41 |
